Independent systematic reviews of the totality of the evidence by governments and international agencies throughout the world uniformly conclude that population-wide interventions to reduce salt are beneficial for health. However, some scientists continue to produce and cite studies with paradoxical findings that conflict with the evidence base To address this problem, a consortium of national and international health and scientific organizations is leading a program of work through its Standards for Salt Research group. The objective of this consortium is to develop a clear set of processes and criteria to which new scientific projects relating to salt should adhere, in order to achieve at least a minimum quality of research in the field. 10 While general criteria for judging the scientific evidence for studies are available, 11 they do not address the complexity inherent in accurately assessing salt intake and its relationship with health outcomes. The new Standards for Salt
| BACKGROUND
Independent systematic reviews of the totality of the evidence by governments and international agencies throughout the world uniformly conclude that population-wide interventions to reduce salt are beneficial for health. However, some scientists continue to produce and cite studies with paradoxical findings that conflict with the evidence base used to develop national and World Health Organization (WHO) guidelines on salt reduction. [1] [2] [3] [4] [5] While conflicting studies are not uncommon in any area of research, 6 in the case of salt, such studies attract widespread attention in the media; misinform program leaders, clinicians, and the general public; and impede program implementation. Such impediments to progress have occurred despite the fact that the designs and methods of studies with paradoxical findings have been criticized by international experts who highlight the fact that the results are not valid. [7] [8] [9] To address this problem, a consortium of national and international health and scientific organizations is leading a program of work through its Standards for Salt Research group. The objective of this consortium is to develop a clear set of processes and criteria to which new scientific projects relating to salt should adhere, in order to achieve at least a minimum quality of research in the field. 10 While general criteria for judging the scientific evidence for studies are available, 11 they do not address the complexity inherent in accurately assessing salt intake and its relationship with health outcomes. The new Standards for Salt
Research will help to ensure that only robust scientific studies are used when national and international recommendations relating to salt reduction are reviewed.
In the meantime, the objective of this paper is to provide an overview of the main arguments used against reducing salt and to counter these arguments with evidence in support of reducing population-wide salt intake. This work updates previous similar reviews that have explained some of the controversies. [12] [13] [14] The intent of this paper is to assist policy makers, program implementers, and clinicians in understanding the science in support of salt reduction and provide them with tools to counter arguments against population-wide salt reduction. Nevertheless, multiple independent review processes in different countries [15] [16] [17] [18] [19] have all concluded that typical dietary salt intake is too high, that it creates serious health problems, and that consequently salt intake should be reduced. The current WHO recommendation is that salt (sodium chloride) intake should be <5 g/d* for adults, with lower levels in children based on their lower caloric needs. 20 The evidence supporting the need to reduce salt and the impact of reducing salt on health is increasing. [21] [22] [23] However, every year there are a few controversial studies that get most of the media coverage and cause some people to question current recommendations. These studies are usually linked to a small group of individuals, several with ties to commercial interests. 14 Such studies are not appropriately designed to assess the association between salt intake and disease as outlined below.
| Main
Response: Reducing salt intake would save millions of lives a year globally.
High dietary salt is associated with wide-ranging health problems including hypertension, stroke, CVD, bone demineralization, kidney stones, gastric cancer, and kidney disease. [24] [25] [26] [27] [28] [29] finding that suggests that nonhypertensive persons will also benefit from reductions in BP. The long-term follow-up from the TOHP studies, which showed that reduced sodium was associated with reduced CVD, were all performed in prehypertensive patients. 56 Reductions in CVD are related to the extent to which BP is reduced as well as to the absolute cardiovascular risk of the study population. [51] [52] [53] [54] 57 The controversy arises from retrospective nonrandomized analyses of studies that include individuals who are already sick. Some such studies have found a U-or J-shaped curve that can be explained by reverse causality (whereby BP may be low because of preclinical or prevalent diseases such as myocardial infarction or heart failure, which then lead to increased risk of premature death). [1] [2] [3] 58 Studies where aggressive BP-lowering therapy is used in populations susceptible to clinical hypotension may also cause cardiovascular and renal disease. 59 A recent study that suggested a relationship between reduced BP and increased CVD events included patients with diabetes, and therefore treatment and other factors were likely to have influenced the results. 60 Such studies do not provide evidence to counter support for population-wide salt reduction strategies. 7, 8, [61] [62] [63] An overview of some of the main weaknesses in these studies is provided below. The existing evidence is strong enough to support the implementation of strategies to reduce salt intake. Meta-analyses of cohort studies of salt intake in healthy populations, or where filters were used to exclude low-quality research, have also shown that salt intake is associated with CVD. 21, 67 Long-term experience with salt reduction in Finland, Japan, and the United Kingdom has shown an association between salt reduction and reduced BP and CVD at the population level. 41, 68 Long-term follow-up of individuals in the TOHP trials, which carefully assessed usual salt intake through repeat 24-hour urine collections, found that salt intake <2300 mg/d was associated with reduced CVD. 56, 69 Response: It is important to emphasize that consumption of <3
of sodium a day is not considered low sodium consumption 70 and that such levels are not associated with increased CVD events and mortality.
Population salt intake for communities with diets that do not have added salt are nearly all below 1 g of sodium (2.5 g of salt) per day. [71] [72] [73] So, although sodium is required for proper bodily function, the minimum physiological amount required is <1 g of sodium per day. 70 Very few populations are currently consuming such low amounts, but in the few remaining hunter-gatherer populations where they do, BP does not rise with age and hypertension and CVD are uncommon. 37, 74, 75 Reliable vital statistics are unavailable in these isolated populations, but mortality appears to be related to infectious diseases and other problems of economically developing regions that are unrelated to salt intake.
While some of the studies that suggest lower amounts of dietary salt are associated with increased CVD events and mortality are based on very large numbers of participants, the methodologies are seriously flawed. Hence, their findings should be interpreted with caution and are not appropriate to guide policy. Systematic reviews of cohort studies that have criteria to exclude lower-quality studies, as well as systematic reviews of RCTs, have found that CVD is reduced (not increased) with lower intakes of dietary sodium. [21] [22] [23] 51, 67 Some of the common methodological problems have been addressed extensively in previous reviews 7, 63 and are summarized as follows:
• Measurement error: The most accurate technique to estimate usual dietary salt intake is the collection of multiple, high-quality 24-hour urine samples. A single urine sample is often used to estimate usual intake; however, this is also less accurate because of large day-to-day variation in dietary intake and because excretion varies widely even with a fixed salt intake. 76, 77 Several of the studies showing a J-shaped relationship between salt intake and health outcomes rely on a single spot urine assessment to estimate each person's long-term usual sodium intake. 1,2 Single spot urine sodium samples cannot accurately assess an individual's usual salt intake, because sodium intake varies meal to meal and day to day and is also impacted by seasonal food availability. [78] [79] [80] Other studies have had a large proportion of 24-hour urine collections that were incomplete, leading to inaccurate estimates of salt intake that would impact the results. 4 Incomplete 24-hour urine collections have lower sodium levels and do not reflect true intake. 81, 82 Other studies have used food surveys that may also not reliably estimate salt intake. 83 In contrast, a follow-up study of participants in the TOHP study used multiple 24-hour sodium measurements and documented that people with lower sodium intakes have a lower risk of CVD and total mortality. More recent analysis has shown that this relationship is still present after a median of 24 years of follow-up, with no evidence of a J-shaped curve. 56, 69 • Reverse causality: In observational studies, persons consuming the least salt may be more likely to have the highest risk of cardiovascular events and death because they were already ill when they entered the study-the problem known as "reverse causation." 7, 84 These people are likely to consume fewer calories and therefore eat less salt because they are ill, rather than being ill as a result of eating less salt.
For example, in the PURE study, older age, having diabetes, and having a history of CVD were more common among patients with lower estimated sodium intakes than those with higher intakes. 63 • Confounding factors: Residual confounding cannot be excluded in observational studies, even when multiple factors are controlled for in the analysis. 7, 84 Specifically, studies often do not assess or control for factors that may address the health outcome of interest.
Why are there no randomized clinical trials proving that salt reduction reduces CVD?
These must be performed to provide robust data proving that salt reduction reduces CVD before we implement interventions.
Aren't low levels of sodium consumption associated with in-
creased CVD events and mortality? Some studies show that low levels of sodium (<3000 mg sodium or 7.5 g salt/d) are associated with increased mortality, especially in nonhypertensive persons. The most recent study quoted is the Prospective Urban
Rural Epidemiology (PURE) study.
Such factors may include chronic kidney disease, family history of CVD, and levels of or changes in nutrient or calorie intake (which might be related to age, physical activity, or chronic disease status).
RCTs, such as TOHP, 49 control for confounding factors through randomization at baseline and therefore provide a higher standard of evidence than observational studies. 78, [85] [86] [87] There is ongoing research to examine the potential for use of spot urine samples from a large sample of the population to estimate mean population salt intake. 88 However, spot urine samples do not provide an accurate assessment of an individual's intake. The reasons are as follows:
• Salt intake varies from day to day and from meal to meal. 4, [79] [80] [81] [82] [83] Therefore, the sodium content of a spot urine sample reflects what was just eaten rather than usual salt intake over an extended period in an individual. 8, 80 • Other factors affect spot urine sodium excretion concentration and include state of hydration, posture, renal function, diurnal variation, and other regulatory functions. 89, 90 • The equations used to calculate 24-hour salt intake from spot urine samples include several variables strongly associated with disease outcomes (age, sex, and urine creatinine concentration), which means that the estimate is not independent of other potential confounding factors.
• The correlation between spot urine samples and 24-hour urine estimates of salt intake varies from one population to another and so the equations cannot be applied without validation studies. 91 For example, in the main PURE study, the correlation was relatively high at around 0.7; however, the correlation in the PURE China population was <0.3. 92, 93 Also, validation studies show differences of 8000 to 9000 mg sodium per day in spot and 24-hour urine samples from the same individuals even when both are from the same collection day. 92, 93 • Bland-Altman plots of spot urine vs 24-hour urine plot show bias at high and low intakes. Spot urine overestimates at low intake and underestimates at high intake, which means that risk is exaggerated at low intake and underestimated at high intake. Therefore, spot urine samples do not reflect individual intakes well across their range.
| DISCUSSION
Public health policy regarding nutritional exposures and chronic disease outcomes (including CVD and cancer), where diseases develop over decades, is seldom based solely on evidence from RCTs. 94 Although
RCTs are widely regarded as the best evidence to test the effects of a medical therapy, they are often impractical in the context of long-term public health interventions on outcomes that may have multifactorial influences over time. They may also be unethical, particularly if there is already a substantial body of evidence from epidemiological studies and/or intervention studies using intermediate end points, such as BP in the case of salt reduction. 94 To delay implementation of public health policy, in the absence of RCT data providing "direct" evidence, may convey considerable harm to the population, especially if such RCT evidence is unlikely to be forthcoming. 95 For this reason, authoritative bodies have developed tools for systematically appraising the totality of scientific evidence (including experimental, epidemiological, and RCT evidence) in order to develop recommendations aimed at individuals and populations. 96 Despite this, vested interests (including the food industry) may exaggerate any uncertainties that this situation offers in order to prevent or delay government action or regulation. 12, 13, 97 The evidence regarding the harms of diets high in salt is sufficient to justify recommendations from the WHO and other governmental and health-related organizations to reduce population salt intake. 16, 20, 61 For example, there is a "substantial amount of evidence" of a dose-response relationship that dietary salt and salted foods are positively associated with stomach cancer, 28 leading the World Cancer
Research Fund and WHO to conclude that dietary salt and salted foods are a probable cause of this cancer. 20, 96 There is a much larger body of evidence that supports an association between high intake of dietary salt and elevated BP 45 and CVDs, such as myocardial infarction and stroke. 21 On the other hand, the premise that reducing salt intake in populations could cause harm is not supported by a strict application of the criteria used to demonstrate cause and effect. 8 The WHO target to implement population-level interventions to lower dietary salt intake by 30% by 2025 was agreed on by its 194 member states in 2013. 98 The WHO and regional offices have developed a number of different tools to support member states to achieve this target. 99, 100 A 2014 review highlighted the fact that 75 countries already had national programs in place to reduce population salt intake. 101 There is growing evidence of the efficacy of such programs. 102 Evaluations of the more established interventions have also shown that population-level reductions in salt intake have been associated with declines in CVD rates in those populations. 42, 103 The recent publication of paradoxical studies with low-quality methodology should not delay implementation of public health inter- and PURE). 10 An international expert group (the TRUE consortium) has been established and will soon be publishing the criteria that need to be met in order for studies of salt reduction to be reliable.
| CONCLUSIONS
Current recommendations to reduce population sodium intake 20 
